AQR Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190M | Buy |
|
|||||
|
2025
Q1 | $119M | Sell |
|
|||||
|
2024
Q4 | $259M | Buy |
|
|||||
|
2024
Q3 | $212M | Buy |
|
|||||
|
2024
Q2 | $167M | Buy |
|
|||||
|
2024
Q1 | $137M | Buy |
|
|||||
|
2023
Q4 | $97.2M | Buy |
|
|||||
|
2023
Q3 | $42.1M | Buy |
|
|||||
|
2023
Q2 | $33.7M | Buy |
|
|||||
|
2023
Q1 | $22.8M | Buy |
|
|||||
|
2022
Q4 | $12.7M | Sell |
|
|||||
|
2022
Q3 | $11.9M | Buy |
|
|||||
|
2022
Q2 | $3.1M | Sell |
|
|||||
|
2022
Q1 | $6.79M | Sell |
|
|||||
|
2021
Q4 | $8.56M | Buy |
|
|||||
|
2021
Q3 | $4.54M | Buy |
|
|||||
|
2021
Q2 | $3.91M | Sell |
|
|||||
|
2021
Q1 | $4.09M | Buy |
|
|||||
|
2020
Q4 | $1.06M | Sell |
|
|||||
|
2020
Q3 | $4.72M | Buy |
|
|||||
|
2020
Q2 | $5.88M | Buy |
|
|||||
|
2020
Q1 | $2.95M | Buy |
|
|||||
|
2019
Q4 | $2.65M | Buy |
|
|||||
|
2019
Q3 | $1.03M | Buy |
|
|||||
|
2019
Q2 | $850K | Sell |
|
|||||
|
2019
Q1 | $5.43M | Sell |
|
|||||
|
2018
Q4 | $8.54M | Buy |
|
|||||
|
2018
Q3 | $8.12M | Buy |
|
|||||
|
2018
Q2 | $2.7M | Buy |
|
|||||
|
2018
Q1 | $1.3M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $3.4M | Sell |
|
|||||
|
2016
Q4 | $5.72M | Sell |
|
|||||
|
2016
Q3 | $10.4M | Buy |
|
|||||
|
2016
Q2 | $1.14M | Sell |
|
|||||
|
2016
Q1 | $1.15M | Sell |
|
|||||
|
2015
Q4 | $4.12M | Sell |
|
|||||
|
2015
Q3 | $5.33M | Sell |
|
|||||
|
2015
Q2 | $8.7M | Buy |
|
|||||
|
2015
Q1 | $4.54M | Buy |
|
|||||
|
2014
Q4 | $1.41M | Sell |
|
|||||
|
2014
Q3 | $1.12M | Sell |
|
|||||
|
2014
Q2 | $2.88M | Sell |
|
|||||
|
2014
Q1 | $7.33M | Buy |
|
|||||
|
2013
Q4 | $3.41M | Buy |
|
|||||
|
2013
Q3 | $3.66M | Buy |
|
|||||
|
2013
Q2 | $2.51M | Buy |
|